Recent News

Transvaginal Mesh Courthouse

Texas Jury Awards Woman $1.2M in J&J Transvaginal Mesh Case

A Texas jury recently ordered that Johnson & Johnson must pay $1.2 million to a former nurse who was injured by one of the manufacturer’s mesh slings used to treat incontinence. Plaintiff Linda Batiste filed a lawsuit against the pharmaceutical giant when the TVT-O mesh sling implanted in her body to treat stress urinary incontinence [...]

Apr 9, 2014 Read More...

Actos Trial Results in 9 Billion Dollar Verdict

Actos Verdict: Takeda, Eli Lilly Must Pay $9 Billion for Hiding Bladder Cancer Risks

A Louisiana federal jury awarded a man $9 billion in punitive damages and $1.5 million in compensatory damages from Takeda Pharmaceuticals and marketing partner Eli Lilly & Co., claiming the drug companies hid the risks of bladder cancer linked to their Actos diabetes drug. Terrence Allen had been taking Actos to treat his Type 2 [...]

Apr 8, 2014 Read More...

Delores Cipriano alleges Actos gave her bladder cancer

Billion-Dollar Lawsuit Against Actos Resumes Today

The multibillion-dollar trial against Takeda Pharmaceuticals, over Actos and the Type 2 diabetes drug’s link to bladder cancer, resumes today after a two-week hiatus, with experts ready to deliver potentially damaging testimony against the drugmaker. Bertha Triana, 80, and Delores Cipriano, 81, say they developed bladder cancer after taking Actos. Their attorneys are expected to [...]

Apr 7, 2014 Read More...

Black Box Warning on Testosterone Pills

Advocacy Groups: Testosterone Products Need Black-Box Warning About Heart Attack Risk

Despite a growing number of studies pointing to increased heart attack risk with testosterone replacement therapy drugs, the U.S. Food and Drug Administration (FDA) has yet to require warning labels on testosterone products. Drug companies, including AbbVie Inc., which manufactures AndroGel, are marketing their testosterone replacement drugs aggressively to treat “Low T” – a low [...]

Apr 1, 2014 Read More...

Box of Actos

Study Links Actos to Development of Chronic Kidney Disease

Researchers have discovered a link between the diabetes drug Actos and an increased risk of chronic kidney disease. Doctors at Taiwan’s Kaohsiung Medical University found that diabetes patients who took Actos (pioglitazone) to help maintain blood glucose levels were almost four times more likely to develop chronic kidney disease than those who did not take [...]

Mar 27, 2014 Read More...

Injection Needle

FDA Approves Aveed Testosterone Product, with Restrictions

The U.S. Food and Drug Administration (FDA) this month approved the testosterone replacement therapy (TRT) drug Aveed, despite recent studies that show these types of medications significantly increase the risk of heart attacks in many men. FDA officials rejected Aveed three times prior to granting final approval because they needed more information on the drug’s [...]

Mar 13, 2014 Read More...

Loading